Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Titan Pharmaceuticals, Inc. (de)?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Titan Pharmaceuticals, Inc. (de) market cap is $5.52M.
What is the 52-week high for Titan Pharmaceuticals, Inc. (de)?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Titan Pharmaceuticals, Inc. (de) 52 week high is $5.76 as of September 29, 2025.
What is the 52-week low for Titan Pharmaceuticals, Inc. (de)?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Titan Pharmaceuticals, Inc. (de) 52 week low is $3.03 as of September 29, 2025.
What is Titan Pharmaceuticals, Inc. (de) stock price today?
Titan Pharmaceuticals, Inc. (de) stock price today is $4.15.
What was Titan Pharmaceuticals, Inc. (de) stock price yesterday?
Titan Pharmaceuticals, Inc. (de) stock price yesterday was $4.03.
What is the PE ratio of Titan Pharmaceuticals, Inc. (de)?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Titan Pharmaceuticals, Inc. (de)’s P/E ratio is -1.40.
What is the Price-to-Book ratio of Titan Pharmaceuticals, Inc. (de)?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Titan Pharmaceuticals, Inc. (de) P/B ratio is 1.9808.
What is the 50-day moving average of Titan Pharmaceuticals, Inc. (de)?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Titan Pharmaceuticals, Inc. (de) 50-day moving average is $4.38.
TTNP Titan Pharmaceuticals, Inc. (de)